# RadNet Inc. (RDNT) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Healthcare / Diagnostics & Research. Price $73.18, market value $5.8 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). RadNet Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 2.5×**. Each dollar of revenue is priced at 2.5×.
- **Price / book: 5.3×**. The shares trade at 5.3× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **EV / EBITDA: 25.1×**. Enterprise value is 25.1× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.

## Profitability
- **Operating margin: 3.1%**. 3.1% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: -0.9%**. The company reported a net loss over the last twelve months.
- **Return on equity: -1.7%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: 4.0%**. Return on all capital, debt included, is 4.0%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -0.6%**. Each dollar of assets produces -0.6% of profit.

## Growth
- **Revenue growth (1 yr): 11.5%** (3-yr 12.6%/yr, 5-yr 13.7%/yr). Revenue grew 11.5% over the last year, against 13.7% a year compounded over five years.
- **EPS growth (1 yr): -725.0%**. Earnings per share fell 725.0%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 1.00**. Debt is 1.00 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Net debt / EBITDA: 1.3×**. It would take 1.3 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 1.76** (quick 1.76). Current assets cover the next year's liabilities 1.76 times.
- **Altman Z-score: 2.58**. A Z-score of 2.58 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. RadNet Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (8 analysts). 8 analysts cover RadNet Inc.; the consensus is strong_buy, with an average price target of $94.63 (+29% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -3.8%** (YTD 2.5%, 3-mo 9.4%). The shares are down 3.8% over twelve months including dividends.
- **From 52-week high: -14.7%** (44.0% above the low). Trading 15% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 56**. An RSI of 56 is neutral.
- **Beta (1 yr): 1.02** (volatility 42%). Beta of 1.02 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=RDNT · Page: https://foliofundamentals.com/stocks/rdnt

Not investment advice.